Articles By Marcus Johnson
-
Baxter To Split Into Two Companies
3/28/2014
Baxter International has released a statement detailing its intention to break the company into two smaller companies.
-
US And Japanese Regulators Differ On Kidney Disease Drug
3/28/2014
US and Japanese regulators have reached different conclusions on a rare kidney disease drug produced by Otsuka Pharmaceutical Co.
-
University of Florida Researchers Say Gold-Based Drug Shows Promise
3/26/2014
Researchers at the University of Florida have been working on a treatment for osteosarcoma, an aggressive form of bone cancer that affects both humans and dogs. Researchers determined that the drug aurothiomalate, or gold salts, helped to stop cancer cells from forming.
-
Animal Testing Reduced By Creation Of New Drug Research Technology
3/25/2014
New technology is making it easier to develop effective pharamceutical drugs without the use of animal testing.
-
WHO Wants Help Fighting Drug-Resistant TB
3/25/2014
The WHO is asking the international medical and pharamcetuical industries to help combat tuberculosis (TB).
-
Study Claims Patent Trolls Could Affect Drug Companies
3/6/2014
Patent trolls are typically associated with the technology industry and computer software. But a new study released by the University of California Hasting College of the Law professor Robin Feldman and Harvard Law School fellow Nicholson Price claims that patent trolls could soon find their way to the drug industry.
-
Computers Quicken Pace Of Drug Development And Lower Costs
2/26/2014
Kun-Yi Hsin is a researcher working with the Open Biology Unit in order to solve problems related to the high cost of developing pharmaceutical drugs.
-
Moran Eye Center Partners With Drug Company Allergan Inc.
2/21/2014
The Moran Eye Center, which operates as part of the University of Utah, has announced that it will enter into a partnership with pharmaceutical giant Allergan, based out of California.
-
Scripps Researchers Find New Drug Resistance Mechanism For Antibiotics
2/21/2014
Researchers at Scripps Research Institute (TSRI) in Florida have found a new way for drugs to resist the constant mutation of bacteria and continue to remain effective.
-
Type 2 Diabetes Drugs Euro Market To Grow 3.8% Per Year
2/19/2014
A new report from Frost & Sullivan (F&S) forecasts a 3.8% growth every year for the European market of Type 2 diabetes from a value of 9.50 billion euros in 2009 to 15.46 billion euros in 2017.